Search Results

Drugs in development for the treatment of schizophrenia

Author: Emsley, Robin

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 8, August 2009 , pp. 1103-1118(16)

Publisher: Informa Healthcare

Pharmacokinetic Changes of Psychotropic Drugs in Patients with Liver Disease: Implications for Dose Adaptation

Authors: Schlatter, Chantal; Egger, Sabin S.; Tchambaz, Lydia; Krähenbühl, Stephan

Source: Drug Safety, Volume 32, Number 7, 1 July 2009 , pp. 561-578(18)

Publisher: Adis International

Paediatric Atypical Antipsychotic Monitoring Safety (PAMS) Study: Pilot Study in Children and Adolescents in Secondary- and Tertiary-Care Settings

Authors: Rani, Fariz A.; Byrne, Patrick J.; Murray, Macey L.; Carter, Paul; Wong, Ian C.K.

Source: Drug Safety, Volume 32, Number 4, 2009 , pp. 325-333(9)

Publisher: Adis International

Newer antipsychotics no safer than older agents?

Source: Reactions, Volume 1, Number 1236, 2009-01-24 , pp. 4-4(1)

Publisher: Adis International

Treatment of schizophrenia in the 21st Century: beyond the neurotransmitter hypothesis

Authors: Rogers, Donald P; Goldsmith, Carroll-Ann W

Source: Expert Review of Neurotherapeutics, Volume 9, Number 1, January 2009 , pp. 47-54(8)

Publisher: Expert Reviews

Pharmacologic Treatment of Disturbed Sleep in the Elderly

Author: Salzman, Carl

Source: Harvard Review of Psychiatry, Volume 16, Number 5, September 2008 , pp. 271-278(8)

Publisher: Informa Healthcare

Emerging drugs for schizophrenia

Authors: Agid, Ofer; Kapur, Shitij; Remington, Gary

Source: Expert Opinion on Emerging Drugs, Volume 13, Number 3, September 2008 , pp. 479-495(17)

Publisher: Informa Healthcare

Genetic variation and antipsychotic drug effects on serum lipids

Author: Hallman, D Michael

Source: Personalized Medicine, Volume 5, Number 1, January 2008 , pp. 77-81(5)

Publisher: Future Medicine

Parkinsonism and tardive antecollis in frontotemporal dementia - increased sensitivity to newer antipsychotics?

Authors: Czarnecki, K.; Kumar, N.; Josephs, K. A.

Source: European Journal of Neurology, Volume 15, Number 2, February 2008 , pp. 199-201(3)

Publisher: Blackwell Publishing

Experience with risperidone long-acting injection: results of a naturalistic observation study

Authors: Deslandes, Paul; Thomas, Arwel; Faulconbridge, Gwawr; Davies, Wendy

Source: International Journal of Psychiatry in Clinical Practice, Volume 11, Number 3, 2007 , pp. 207-211(5)

Publisher: Informa Healthcare

Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States

Authors: Sun, Shawn X.; Liu, Gordon G.; Christensen, Dale B.; Fu, Alex Z.

Source: Current Medical Research and Opinion, Volume 23, Number 10, October 2007 , pp. 2305-2312(8)

Publisher: Informa Healthcare

Partial Dopamine Receptor Agonists as Newer Atypical Antipsychotics:Intrinsic Activity Appropriate for Treatment of Schizophrenic Patients

Author: Odagaki, Yuji

Source: Central Nervous System Agents in Medicinal Chemistry(Formerly Current Medicinal, Volume 7, Number 3, September 2007 , pp. 156-165(10)

Publisher: Bentham Science Publishers

Depression in Nursing Homes: Ensuring Adequate Treatment

Authors: Llewellyn-Jones, Robert H.; Snowdon, John

Source: CNS Drugs, Volume 21, Number 8, 2007 , pp. 627-640(14)

Publisher: Adis International

Metabolic side effects of antipsychotic medication

Authors: Tschoner, A.; Engl, J.; Laimer, M.; Kaser, S.; Rettenbacher, M.; Fleischhacker, W. W.; Patsch, J. R.; Ebenbichler, C. F.

Source: International Journal of Clinical Practice, Volume 61, Number 8, August 2007 , pp. 1356-1370(15)

Publisher: Blackwell Publishing

Bipolar disorder pharmacotherapy

Authors: Denko, Timothey C; Thase, Michael E

Source: Future Neurology, Volume 2, Number 4, July 2007 , pp. 441-450(10)

Publisher: Future Medicine

Neuroleptic malignant syndrome in elderly patients

Authors: Caroff, Stanley N; Campbell, E Cabrina; Sullivan, Kenneth A

Source: Expert Review of Neurotherapeutics, Volume 7, Number 4, April 2007 , pp. 423-431(9)

Publisher: Expert Reviews

Neurochemistry and Pharmacological Treatments: Where is the Field of Anorexia Nervosa Heading?

Author: Barbarich-Marsteller, Nicole C.

Source: Central Nervous System Agents in Medicinal Chemistry(Formerly Current Medicinal, Volume 7, Number 1, March 2007 , pp. 35-43(9)

Publisher: Bentham Science Publishers

Psychotropic Medications and the Risk of Fracture: A Meta-Analysis

Authors: Takkouche, Bahi; Montes-Martínez, Agustín; Gill, Sudeep S.; Etminan, Mahyar

Source: Drug Safety, Volume 30, Number 2, 2007 , pp. 171-184(14)

Publisher: Adis International

Metabolic Drug Interactions with Newer Antipsychotics: A Comparative Review

Authors: Spina, Edoardo; de Leon, Jose

Source: Basic & Clinical Pharmacology & Toxicology, Volume 100, Number 1, January 2007 , pp. 4-22(19)

Publisher: Blackwell Publishing

Hospitalisation risks in the treatment of schizophrenia in a Medicaid population: comparison of antipsychotic medications

Authors: GIANFRANCESCO, F.; WANG, R. H.; PESA, J.; RAJAGOPALAN, K.

Source: International Journal of Clinical Practice, Volume 60, Number 11, November 2006 , pp. 1419-1424(6)

Publisher: Blackwell Publishing